SC bihormonal artificial pancreas devices that utilise both insulin and glucagon can potentially allow more aggressive insulin treatment than unihormonal devices using only insulin, as glucagon could counteract insulin-induced hypoglycaemia. The gene discussed is GCG; the disease is Hypoglycemia.